Soleno Therapeutics, Inc.

Historical 13F Holders

Symbol
SLNO
CUSIP
834203309
All holders as of
Q1 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 834203309 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 6.9% 4/24/2026
Event 3/31/2026
Adage Capital Partners GP, L.L.C. 13G/A
6.4% 2/12/2025
Event 12/31/2024
State Street Corp 13G 5.2% 5/12/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (9)
Avoro Capital Advisors LLC 13G/A
4.5% 5/15/2026
Event 3/31/2026
Vivo Opportunity Fund Holdings, L.P. 13G/A
4.2% 11/14/2025
Event 9/30/2025
Adage Capital Management, L.P. 13G/A
2.6% 11/13/2025
Event 9/30/2025
Janus Henderson Group PLC 13G/A 2.3% 5/7/2026
Event 4/30/2026
Price T Rowe Associates Inc /MD/ 13G/A 2.0% 5/15/2026
Event 3/31/2026
Nantahala Capital Management, LLC 13G/A
2.0% 8/14/2025
Event 6/30/2025
FMR LLC 13G/A
0.4% 5/7/2026
Event 4/30/2026
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026
Wellington Management Group LLP 13G/A
0% 8/13/2026
Event 6/30/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q1 243 62.4 M $2.09 B
2025 Q4 286 65.0 M $3.01 B
2025 Q3 287 66.0 M $4.46 B
2025 Q2 266 56.9 M $4.76 B
2025 Q1 265 54.6 M $3.90 B
2024 Q4 196 51.0 M $2.29 B
2024 Q3 161 47.1 M $2.38 B
2024 Q2 125 46.5 M $1.90 B
2024 Q1 113 35.2 M $1.51 B
2023 Q4 89 34.4 M $1.38 B
2023 Q3 55 20.3 M $599 M
2023 Q2 23 4.85 M $20.8 M
2023 Q1 21 3.07 M $6.54 M
2022 Q4 28 2.80 M $5.55 M
2022 Q3 22 2.78 M $4.65 M